Table 2.
Demographic. clinical and laboratory features of the patients according to HbA1c groups
| Parameters | HbA1c <7 (n=82) | HbA1c ≥7 (n=225) | P value |
|---|---|---|---|
| Age (years)* | 51.5 (45-57.3) | 52 (45-58) | >0.05 |
| Gender (f/m)** | 45/37 | 138/87 | >0.05 |
| BMI (kg/m²)* | 30.9 (28.4-33.7) | 30.7 (27.2-33.6) | >0.05 |
| Waist circumference (cm)* | 103 (98-110) | 102 (97-109) | >0.05 |
| Disease duration (month)* | 48 (24-72) | 72 (36-132) | <0.001 |
| SBP (mmHg)* | 130 (114-140) | 130 (120-140) | >0.05 |
| DBP (mmHg)* | 75 (65-81) | 80 (70-80) | >0.05 |
| TC (mg/dL)*** | 205.40±45.11 | 208.21±48.55 | >0.05 |
| HDL-C (mg/dL)* | 45 (41-52) | 45 (39-50) | >0.05 |
| LDL-C (mg/dL)*** | 124.55±39.16 | 126.71±44.13 | >0.05 |
| TG (mg/dL)* | 164 (131-198) | 164 (112-233) | >0.05 |
| Creatinine (mg/dL)* | 0.72 (0.62-0.85) | 0.70 (0.59-0.85) | >0.05 |
| MPV (fL)*** | 8.9±0.8 | 9.4±0.9 | <0.001 |
| PCT (%)* | 0.222 (0.195-0.258) | 0.237 (0.195-0.280) | 0.039 |
| PDW (fL)* | 16.0 (15.0-17.0) | 16.6 (15.3-18.0) | 0.002 |
| Platelet Count (x103/uL)* | 251 (226-289) | 248 (209-301) | >0.05 |
| FPG (mg/dL)* | 116 (110-121) | 205 (172-255) | <0.001 |
| HbA1c (%)* | 6.5 (6.2-6.8) | 9.5 (8.2-11.1) | <0.001 |
| WBC (x103/uL)* | 7.3 (6.3-8.1) | 7.5 (6.5-8.7) | >0.05 |
| NLR* | 1.92 (1.40-2.34) | 1.71 (1.40-2.23) | >0.05 |
| PLR* | 107.61 (88.29-129.77) | 106.81 (83.50-138.51) | >0.05 |
| Albuminuria (mg/g Cr)* | 8.83 (2.65-19.88) | 18.43 (7.71-224.53) | <0.001 |
*
Mann-Whitney U (Data are given as median (IQR)).
**
Chi-Square Test.
***
T-Test (Data are given as mean ± SD).
SBP: Systolic Blood Pressure. DBP: Diastolic Blood Pressure. TC: Total Cholesterol. HDL-C: High Density Lipoprotein Cholesterol. LDL-C: Low Density Lipoprotein Cholesterol. TG: Triglyceride. MPV: Mean Platelet Volume. FPG: Fasting Plasma Glucose. HbA1c: Glycosylated Hemoglobin.